Interaction between harmane, a class of β-carboline alkaloids, and the CA1 serotonergic system in modulation of memory acquisition.
This study set to assess the involvement of dorsal hippocampus (CA1) serotonergic system on harmane induced memory acquisition deficit. We used one trial step-down inhibitory avoidancetask to evaluate memory retention and then, open field test to evaluate locomotor activity in adult male NMRI mice. The results showed that pre-training intra-peritoneal (i.p.) administration of harmane (12mgkg) induced impairment of memory acquisition. Pre-training intra-CA1 administration of 5-HT1B1D receptor agonist (CP94253 0.5 and 5ngmouse) and 5-HT2A2B2C receptor agonist (α-methyl 5-HT 50ngmouse) impaired memory acquisition. Furthermore, intra-CA1 administration of 5-HT1B1D receptor antagonist (GR127935 0.5ngmouse) and 5-HT2 receptor antagonist (cinancerine 5ngmouse) improved memory acquisition. In addition, pre-training intra-CA1 injection of sub-threshold dose of CP94253 (0.05ngmouse) and α-methyl 5-HT (5ngmouse) potentiated impairment of memory acquisition induced by harmane (12mgkg, i.p.). On the other hand, pre-training intra-CA1 infusion of sub-threshold dose of GR127935 (0.05ngmouse) and cinancerine (0.5ngmouse) with the administration of harmane (12mgkg, i.p.) weakened impairment of memory acquisition. Moreover, all above doses of drugs did not change locomotor activity. The present findings suggest that there is an interaction between harmane and the CA1 serotonergic system in modulation of memory acquisition.